Correlation Between AN2 Therapeutics and Apexigen
Can any of the company-specific risk be diversified away by investing in both AN2 Therapeutics and Apexigen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AN2 Therapeutics and Apexigen into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between AN2 Therapeutics and Apexigen, you can compare the effects of market volatilities on AN2 Therapeutics and Apexigen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AN2 Therapeutics with a short position of Apexigen. Check out your portfolio center. Please also check ongoing floating volatility patterns of AN2 Therapeutics and Apexigen.
Diversification Opportunities for AN2 Therapeutics and Apexigen
-0.14 | Correlation Coefficient |
Good diversification
The 3 months correlation between AN2 and Apexigen is -0.14. Overlapping area represents the amount of risk that can be diversified away by holding AN2 Therapeutics and Apexigen in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Apexigen and AN2 Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AN2 Therapeutics are associated (or correlated) with Apexigen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Apexigen has no effect on the direction of AN2 Therapeutics i.e., AN2 Therapeutics and Apexigen go up and down completely randomly.
Pair Corralation between AN2 Therapeutics and Apexigen
If you would invest 43.00 in Apexigen on September 22, 2024 and sell it today you would earn a total of 0.00 from holding Apexigen or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 0.79% |
Values | Daily Returns |
AN2 Therapeutics vs. Apexigen
Performance |
Timeline |
AN2 Therapeutics |
Apexigen |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
AN2 Therapeutics and Apexigen Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with AN2 Therapeutics and Apexigen
The main advantage of trading using opposite AN2 Therapeutics and Apexigen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AN2 Therapeutics position performs unexpectedly, Apexigen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Apexigen will offset losses from the drop in Apexigen's long position.AN2 Therapeutics vs. Aerovate Therapeutics | AN2 Therapeutics vs. Adagene | AN2 Therapeutics vs. Acrivon Therapeutics, Common | AN2 Therapeutics vs. Rezolute |
Apexigen vs. Leap Therapeutics | Apexigen vs. Zura Bio Limited | Apexigen vs. X4 Pharmaceuticals | Apexigen vs. Phio Pharmaceuticals Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Other Complementary Tools
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Equity Valuation Check real value of public entities based on technical and fundamental data |